Prothena Corp Public (PRTA) Total Current Liabilities (2012 - 2026)

Prothena Corp Public's (PRTA) quarterly Total Current Liabilities came in at $32.5 million in Q1 2026, down 32.9% year-on-year from $48.5 million in Q1 2025, and down 20.39% quarter-over-quarter from $40.8 million in Q4 2025.

Prothena Corp Public (PRTA) Total Current Liabilities (2012 - 2026) Analysis & Trends

Prothena Corp Public's Total Current Liabilities history runs 15 years deep, the most recent figure standing at $32.5 million for Q1 2026.

  • On a quarterly basis, Total Current Liabilities fell 32.9% year-over-year to $32.5 million in Q1 2026; TTM through Mar 2026 was $32.5 million, a 32.9% decrease from a year earlier, with the FY2025 full-year figure at $40.8 million, down 15.79% from the prior year.
  • Total Current Liabilities slipped to $32.5 million in Q1 2026 per PRTA's latest filing, from $40.8 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $71.6 million in Q2 2023 and bottomed at $32.5 million in Q1 2026.
  • The 5-year median for Total Current Liabilities is $48.5 million (2024), against an average of $49.1 million.
  • Across the five-year window, Total Current Liabilities surged 78.44% in 2023 and sank 34.68% in 2024, its largest moves.
  • Year by year, Total Current Liabilities stood at $50.1 million in 2022, then increased by 13.45% to $56.9 million in 2023, then fell by 14.75% to $48.5 million in 2024, then fell by 15.79% to $40.8 million in 2025, then retreated by 20.39% to $32.5 million in 2026.
  • Per Business Quant, the three latest PRTA Total Current Liabilities figures stand at $32.5 million (Q1 2026), $40.8 million (Q4 2025), and $51.4 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 56.01 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 66.94 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 13.42 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.81 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 3.88 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 5.11 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 289.60 Mn
10 Prothena Corp Public 467.80 Mn 138.33 Mn - 32.52 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 32.52 Mn
Dec 31, 2025 40.84 Mn
Sep 30, 2025 51.44 Mn
Jun 30, 2025 67.81 Mn
Mar 31, 2025 48.46 Mn
Dec 31, 2024 48.50 Mn
Sep 30, 2024 46.42 Mn
Jun 30, 2024 46.74 Mn
Mar 31, 2024 43.27 Mn
Dec 31, 2023 56.89 Mn
Sep 30, 2023 53.37 Mn
Jun 30, 2023 71.57 Mn
Mar 31, 2023 48.88 Mn
Dec 31, 2022 50.15 Mn
Sep 30, 2022 50.60 Mn
Jun 30, 2022 40.11 Mn
Mar 31, 2022 36.50 Mn
Dec 31, 2021 33.45 Mn
Sep 30, 2021 29.20 Mn
Jun 30, 2021 52.90 Mn